• Health & Medicine

Launch of trial of ‘master switch’ drug to treat several cancer types

Cancer Research UK and its commercial arm Cancer Research Technology (CRT) are launching a trial of an experimental drug shown to simultaneously block many enzymes that control cancer cell growth and death. Cancer Research UK and its commercial arm Cancer Research Technology (CRT) are launching a trial of an experimental drug shown to simultaneously block many enzymes that control cancer cell growth and death.

17 January 2013

• Health & Medicine

Clinical trials: Helping more children beat cancer every year

During childhood cancer awareness month we focus on how clinical trials are a vital part of helping children beat cancer. During childhood cancer awareness month we focus on how clinical trials are a vital part of helping children beat cancer.

18 December 2012

• Health & Medicine

Trial reveals 10 years of tamoxifen halves later deaths from commonest kind of cancer

Ten years of tamoxifen treatment can approximately halve the number of deaths from the most common form of breast cancer during the second decade after diagnosis, according to the results of the Cancer Research UK- funded ATLAS trial published in the Lancet today. Ten years of tamoxifen treatment can approximately halve the number of deaths from the most common form of breast cancer during the second decade after diagnosis, according to the results of the Cancer Research UK- funded ATLAS trial published in the Lancet today.

5 December 2012

• Health & Medicine

Expert opinion: Professor Dion Morton - combining chemo and surgery in colon cancer

3 December 2012

• Health & Medicine

Cancer Research UK and Lorus to co-develop first-of-kind drug, IL-17E, to treat solid tumours

Cancer Research UK’s Drug Development Office; Cancer Research Technology, the charity's commercial arm; and biopharmaceutical company, Lorus Therapeutics Inc., have partnered to take a new therapy with the potential to treat solid tumours, into its first clinical trial. Cancer Research UK’s Drug Development Office; Cancer Research Technology, the charity's commercial arm; and biopharmaceutical company, Lorus Therapeutics Inc., have partnered to take a new therapy with the potential to treat solid tumours, into its first clinical trial.

27 November 2012

• Health & Medicine

Bowel cancer 'chemo swap' shrinks tumours, making surgery safer and easier

Giving some bowel cancer patients six weeks of chemotherapy before surgery can significantly shrink their tumour, making it easier to remove and potentially reducing the chances of the cancer coming back, according to results from a major Cancer Research UK-funded pilot study published this month in Lancet Oncology. Giving some bowel cancer patients six weeks of chemotherapy before surgery can significantly shrink their tumour, making it easier to remove and potentially reducing the chances of the cancer coming back, according to results from a major Cancer Research UK-funded pilot study published this month in Lancet Oncology.

1 November 2012

• Health & Medicine

A vitamin pill a day keeps cancer away? Unlikely

19 October 2012

• Health & Medicine

Trial offers new hope to children and adults with muscle cancer

A Cancer Research UK funded trial will offer new treatments for children and adults with a form of muscle cancer called rhabdomyosarcoma that has returned or does not respond to current treatments. A Cancer Research UK funded trial will offer new treatments for children and adults with a form of muscle cancer called rhabdomyosarcoma that has returned or does not respond to current treatments.

19 October 2012

• Health & Medicine

Why we’re Standing Up To Cancer

17 October 2012

• Science & Technology
• Health & Medicine

Research into new treatments shouldn’t be hampered by red tape

19 September 2012

• Science & Technology
• Health & Medicine

Podcast: Curry chemical on trial, death rates fall, ASCO conference highlights and more

18 June 2012